Myeloproliferative Neoplasms: an In-depth Case-control Study

CompletedOBSERVATIONAL
Enrollment

234

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

July 31, 2014

Study Completion Date

June 30, 2015

Conditions
Polycythemia VeraEssential ThrombocythemiaPrimary Myelofibrosis
Interventions
OTHER

Methodological pens

Randomisation of branded pen, non-branded pen and no pen

OTHER

Methodological compensation

Randomisation of a £10 monetary reimbursement for expenses on completion of the study

OTHER

Methodological trolley tokens

Trolley tokens to be randomly assigned to half of cases and General Practice controls.

Trial Locations (3)

SO16 6YD

University Hospitals Southampton NHS Foundation Trust, Southampton

BT12 6BJ

Belfast Health And Social Care Trust, Belfast

BT389EX

Queen's University Belfast, Belfast

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

University Hospital Southampton NHS Foundation Trust

OTHER

collaborator

University of Manchester

OTHER

collaborator

Western Australian Institute for Medical Research

OTHER

collaborator

Mayo Clinic

OTHER

lead

Queen's University, Belfast

OTHER

NCT01831635 - Myeloproliferative Neoplasms: an In-depth Case-control Study | Biotech Hunter | Biotech Hunter